Abstract
Background A 51-year-old white man with chronic obstructive pulmonary disease who was infected with HCV genotype 2b presented with sudden left-sided hearing loss. He had been taking pegylated interferon (PEG-IFN) and ribavirin treatment for 6 weeks without any notable adverse effects. He had also been taking naproxen for 2 years for the treatment of chronic back pain.
Investigations Physical examination, laboratory tests, including complete blood counts and liver function tests, otoscopic examination, audiogram, MRI of the middle ear, objective causality assessment using the Naranjo probability scale.
Diagnosis PEG-IFN-induced acute sensorineural hearing loss.
Management Prednisone while maintaining treatment with PEG-IFN.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dusheiko G (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26 (Suppl 1): S112–S121
Rutkove SB (1997) An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a. Arch Neurol 54: 907–908
Elloumi H et al. (2007) Sudden hearing loss associated with peginterferon and ribavarin combination therapy during hepatitis C treatment. World J Gastroenterol 13: 5411–5412
Ogundipe O and Smith S (2000) Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with hemorrhagic disorders. Hemophilia 6: 110–112
Quattrini A et al. (1997) Axonal neuropathy associated with interferon- treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol 94: 504–508
Fattovich G et al. (1996) A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 24: 38–47
Formann E et al. (2004) Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 99: 873–877
Kanda Y et al. (1995) Interferon-induced sudden hearing loss. Audiology 3: 98–102
Wong VK et al. (2005) Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy. World J Gastroenterol 14: 5392–5393
Piekarska A et al. (2007) Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin. Int J Audiol 46: 345–350
Calvet MC and Gresser I (1979) Interferon enhances the excitability of cultured neurons. Nature 278: 558–560
Tunca A et al. (2004) Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report. Turk J Gastroenterol 15: 97–99
Cadoni G et al. (1998) Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune–microvascular pathogenesis. J Laryngol Otol 112: 962–963
Akyol MU et al. (2001) Investigation of the ototoxic effects of interferon α2a on the mouse cochlea. Otolaryngol Head Neck Surg 124: 107–110
Repatriation General Hospital Pharmacy E-Bulletin: Naranjo reverse drug reaction probability scale [http://www.finlay-online.com/albarranschoolofmedicine/Naranjo%20Adverse %20Drug%20Reaction%20Questionjaire.pdf] (accessed 3 November 2008)
Wilson WR et al. (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol 106: 772–776
Conlin AE et al. (2007) Treatment of sudden sensorineural searing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg 133: 582–586
McHutchison JG et al. (2001) Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial. J Clin Gastroenterol 32: 133–137
Acknowledgements
We thank Andrea Stevens, an audiologist, for her assistance in interpreting the audiogram and in representing the findings as a graph.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Le, V., Bader, T. & Fazili, J. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. Nat Rev Gastroenterol Hepatol 6, 57–60 (2009). https://doi.org/10.1038/ncpgasthep1317
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1317
This article is cited by
-
Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy
Indian Journal of Gastroenterology (2011)